The Physician Value Index: A Framework for Measuring Pharmaceutical Marketing Performance
A conversation with Mark Goldstone and Venkat Gullapalli, MD, Co-CEO, Medikly, about a better way to reach, engage and understand healthcare professionals (HCPs) by gaining insights into the HCP journey through various digital touch points and highlighting how these touch points impact the behaviors and preferences of HCPs and their intent to prescribe.
Customer Focus First: A New Pharma Commercial Model
A conversation with Rob Halkes, MHA, Managing Consultant/Owner, Health Business Consult, about a new commercial model for a pharmaceutical market approach, which puts the customer's needs first.
Why is Putting the Patient at the Center So Difficult? Enough is Enough. It’s...
A conversation with Dyan Bryson, VP, Patient Enablement Services at Indegene Lifesystems Pvt. Ltd. and Managing Director, Inspired Health Strategies, LLC, about what it will take for the pharmaceutical industry to become more 'patient-centric' and the benefits for pharma and patients.
Get Social, #GetFit and Get Healthy: How GE Healthcare Uses Social Media & Gaming...
A conversation with Angel Gonzalez, Founder & CEO, Ideagoras, Veronica Botet, Global Manager, Digital and Social Media, GE Healthcare. The discussion focuses on the #GetFit initiative, a worldwide competition and social media campaign designed to raise public awareness about cancer prevention and to recognize competitors with external industry awards.
Social Media for Pharma C-Suite Dummies: The Need for Social Media Training
A conversation with Alexandra Fulford, Principal at Healthcare Management Consultants, Ltd and known as @Pharmaguapa on Twitter. We discuss the need for social media training of pharmaceutical senior managers.
The Marketing of Low T (“Low Testosterone”): Ghostwriting, Celebrities, Symptom Quizzes, Numbers
A conversation with Adriane Fugh-Berman, MD, Associate professor at Georgetown University Medical Center and Director of PharmedOut. We discuss how the marketing of Androgel uses ghostwriting, celebrities, symptom quizzes, and numbers to convince men and physicians that 'low testosterone' (Low T) is a medical condition that should be treated.
Beyond Mobile Medical App Guidance: What to Worry About After FDA Publishes Its “Final”...
A conversation with Bradley Merrill Thompson, Member of the Firm at Epstein Becker & Green and General Counsel to the mHealth Regulatory Coalition. We discuss prospects for FDA's final guidance on regulation of mobile medical apps (MMAs) and other regulatory issues that the mobile health community and FDA will need to face after publication of the 'final' guidelines.
“Safe” Social Media for Pharma Marketers: Alliance Health’s Safe Social API
A conversation with Dan Hickey, SVP of Products at Alliance Health, about Alliance Health's Safe Social API, which enables marketing partners in the pharmaceutical industry to build interactive pages within the company's network of condition-specific social health networks.
Physicians Unprepared for Sunshine Law: Survey Reveals Physicians Prefer Filtered Sunshine
A conversation with Michaeline Daboul, CEO of MMIS, about her company's third annual survey of doctors and their knowledge of the Sunshine Law, which is part of Obamacare. The survey found that physicians are actually less informed than they were one year ago.
Pharma’s Legal Assault Against Off Label Speech Restrictions
A discussion with Darshan Kulkarni, Principal Attorney at the Kulkarni Law Firm, about recent court cases involving pharma's right to speak to physicians about off-label uses of approved drugs.
